Public Release: 

Journal of Alzheimer's Disease achieves significant impact factor

University of Texas at San Antonio

International publisher IOS Press and the Editorial Board of the Journal of Alzheimer's Disease (JAD) are proud to announce that the journal has achieved a 3.058 Impact Factor the first year that a rating has been assigned to this title. This is significantly higher than the only other journal devoted solely to Alzheimer's disease (AD) research indexed in Thomson Scientific's Journal Citation Reports 2006.

Editors-in-Chief George Perry and Mark A. Smith commented, "We are extremely pleased to have quantitative evidence of the high regard in which the Journal of Alzheimer's Disease is held by researchers and clinicians working in AD and the extent to which JAD's articles are cited throughout the medical and scientific literature. The dedication of the entire editorial board, contributing authors and our publisher, IOS Press, has certainly contributed to the success of the journal."

"The Journal of Alzheimer's Disease is one of our flagship publications," stated Einar Fredriksson, Director of IOS Press. "As publisher, one of our primary goals is to provide an open forum for original research that will expedite the fundamental understanding of Alzheimer's disease. It is particularly gratifying to see the impact that this journal is having in the field. As the Journal of Alzheimer's Disease continues to grow and flourish, future plans include increasing to 12 issues in 2008 and the inclusion of a Review Article section under the editorial guidance of Ralph N. Martins of the Edith Cowan University, Perth, Australia."


The Journal of Alzheimer's Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease and clinical trial outcomes.

About IOS Press

Celebrating its 20th anniversary, IOS Press is a rapidly expanding scientific, technical, medical and professional publishing house focusing on a broad range of subject areas. Headquartered in Amsterdam, IOS Press publishes approximately 150 new books each year, including Delft University Press titles, and 85 international journals, covering topics ranging from computer science and mathematics to medicine and the natural sciences. Electronic access to all journals and most book series is now available. IOS Press also maintains offices in the Washington, DC area and Berlin as well as a co-publishing relationship with Ohmsha, Ltd (Tokyo).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.